Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 USD | -23.08% | -14.29% | -96.02% |
04-15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
2023 | Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-96.02% | 529K | |
+2.49% | 108B | |
+9.60% | 105B | |
+1.57% | 23.46B | |
-11.26% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.29% | 17.19B | |
+6.31% | 13.99B | |
+35.19% | 12.53B |
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock
- News Acorda Therapeutics, Inc.
- Earnings Flash (ACOR) ACORDA THERAPEUTICS Reports Q2 Revenue $29.7M